Presentation is loading. Please wait.

Presentation is loading. Please wait.

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,

Published byJade Knight Modified over 6 years ago

Similar presentations

Presentation on theme: "Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,"— Presentation transcript:

1 Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand, MD, PhD, Bogdan Borz, MD, Akira Furuta, MD, Karim Bejar, MD, Alexandre Canville, MD, Ali Farhat, MD, Chiara Fraccaro, MD, Matthieu Godin, MD, Christophe Tron, MD, Rahul Sakhuja, MD, Alain Cribier, MD  American Heart Journal  Volume 167, Issue 2, Pages (February 2014) DOI: /j.ahj Copyright © 2014 Mosby, Inc. Terms and Conditions

2 Figure 1 Kaplan-Meier estimated survival at 5 years after BAV.
American Heart Journal  , DOI: ( /j.ahj ) Copyright © 2014 Mosby, Inc. Terms and Conditions

3 Figure 2 Kaplan-Meier estimated survival at 5 years in TAVR patients with or without prior BAV. American Heart Journal  , DOI: ( /j.ahj ) Copyright © 2014 Mosby, Inc. Terms and Conditions

Download ppt "Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,"

Similar presentations

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
Downstream coronary effects of drug-eluting stents

Downstream coronary effects of drug-eluting stents
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD)

Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD)
Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis  Ashok.

Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis  Ashok.
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.
Comparative Survival After Transapical, Direct Aortic, and Subclavian Transcatheter Aortic Valve Implantation (Data from the UK TAVI Registry)  Georg.

Comparative Survival After Transapical, Direct Aortic, and Subclavian Transcatheter Aortic Valve Implantation (Data from the UK TAVI Registry)  Georg.
A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement 

A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement 
The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.
National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith.

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith.
Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.
Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients?  Lars G. Svensson, MD, PhD  The Journal of Thoracic and.

Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients?  Lars G. Svensson, MD, PhD  The Journal of Thoracic and.

Similar presentations

Ads by Google